This person is not registered. Is this you?


Profile Details
Helen X. Chen
Affiliations:

National Cancer Institute,



 
, US
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@ChenBalbus
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 12668 / 3065 (What's this?)
Accomplish Score: 24
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 33
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 4 (24 / 0)
  • PURPOSE: Cisplatin-based chemotherapy is the first line treatment for several cancers including bladder cancer (BC). ()
  • BACKGROUND: The aim of this study was to determine whether a modified enhanced recovery after surgery (mERAS) protocol has a positive effect on the recovery of aged patients with esophageal cancer undergoing esophagectomy. ()
  • PURPOSE: Cardamonin inhibits the proliferation of SKOV3 cells by suppressing the mammalian target of rapamycin complex 1 (mTORC1). ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.